Pink Warrior 2: Teleconference-based Gaming Support (PW2)

Pink Warrior 2.0: Teleconference Support Group Toolkit for Breast Cancer Survivors

Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-only 1 in 3 survivors met physical activity recommendations of 150 minutes of moderate-intensity activity per week. Physical activity interventions have shown effectiveness in helping breast cancer survivors increase physical activity during treatment, but limited evidence-based physical activity interventions have been incorporated into the clinic and community. To address this limitation, the investigators are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior.

The goal of this study is to compare an intervention that uses active games versus an intervention uses pedometer to encourage physical activity such as walking within breast cancer survivors in active cancer treatment. The study will include breast cancer survivor between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants will be randomized to participate in the support group using the active video game-based physical activity intervention (Wii and Xbox active games) or to participate in the existing UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators hypothesize that by engaging in active video gaming, breast cancer survivors will be motivated to initiate and maintain physical activity during treatment. This will ultimately increase functional capacity and prevent functional disability in breast cancer survivors.

Study Overview

Detailed Description

Increasing and maintaining physical activity among female breast cancer (BC) survivors during treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decline of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-less than 30% of survivors met physical activity recommendations. Physical activity interventions have shown effectiveness in helping BC survivors increase activity during treatment, but limited evidence-based activity interventions have been disseminated into the clinic and community. To address this limitation, we are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the feasibility of implementing active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Participants (N = 60) will be randomized to participate in the support group using the active video game-based physical activity intervention or to participate in the existing UTMB breast cancer support group with pedometers. Our specific aims are:

Aim 1: Evaluate the feasibility and acceptability of active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Measures of feasibility will include weekly attendance records, number of completed home-based worksheets, number of participants completing the program activities, technological issues, and adverse events.

Aim 2: Compare the support group using the active video game-based physical activity intervention to the existing UTMB breast cancer support group with pedometer. Primary outcomes will be changes in physical activity. Secondary outcomes will be changes in physical function, dietary pattern, and quality of life.

Aim 3: Develop tools for implementation of the Pink Warrior intervention within the clinic and community settings. A trainer's manual for the Pink Warrior intervention will be developed and UTMB Breast Cancer Support Group facilitators will be trained by research staff to implement the program.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Galveston, Texas, United States, 77555
        • The University of Texas Medical Branch
      • Houston, Texas, United States, 77054
        • UT MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Provide informed consent
  2. Diagnosed with primary female breast cancer
  3. 55 years to 79
  4. Able to speak, read, and write in English
  5. Able to travel to UTMB locations and/or MD Anderson Victory Lakes
  6. Able to move arms and les as well as ambulate
  7. Has a smartphone, tablet or computer and daily access to a reliable internet

Exclusion Criteria:

  1. Pregnancy
  2. Diagnosed dementia
  3. Currently engage in 150 minutes or more of planned moderate intensity physical activity
  4. Currently involved in another physical activity intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active video game teleconference support group
Participants will attend enhanced support group meetings via zoom teleconferencing software. Support group meetings will include group play of active video games and discussion of survivorship topics. Participants will self-monitor physical activity using Fitbit wearable activity monitors and will receive a water bottle and tote bag.
12 sessions of teleconferenced support group meetings, including active video game play + self-paced walking monitored by Fitbit wearable device
Active Comparator: Standard support group + pedometer
Participants will attend standard in-person support groups currently offered by the UTMB Breast Health Center. They will also receive a standard pedometer and a water bottle and tote bag.
3 monthly sessions of in-person standard support group meetings + self-paced walking monitored by pedometer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking Physical Activity as Measured by Change in Daily Steps From Baseline to 14 Weeks
Time Frame: Baseline to 14 weeks
Difference in mean of daily steps taken from Actigraph accelerometer worn for 7 day period from baseline assessment to 14 week assessment
Baseline to 14 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life as Measured by the Change in FACT-B Scores From Baseline to 14 Weeks
Time Frame: Baseline to 14 weeks
Quality of life score as measured by the Functional Assessment of Cancer Therapy-Breast measure at follow-up, scored for physical, social, emotional, functional, and breast well-being (here we report the total score of these subscales). The range for this scale is 0-123, with 0 indicating a better outcome.
Baseline to 14 weeks
Physical Performance as Measured by the Change in Short Physical Performance Battery Scores From Baseline to 14 Weeks
Time Frame: Baseline to 14 weeks
Difference in physical performance as measured by Short Physical Performance Battery from baseline to 14 weeks. The numbers reported here are the sum of scores from the subscales. The range for this measure is between 0-12, with lower scores indicating better outcomes.
Baseline to 14 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue
Time Frame: Baseline to 14 weeks
Fatigue score as measured by the PROMIS cancer-specific instrument (PROMIS-Ca Bank v1.1-Fatigue)
Baseline to 14 weeks
Self-regulation: Exercise Goal-Setting (EGS) and Exercise Planning and Scheduling Scale (EPS)
Time Frame: Baseline to 14 weeks
Goal-setting and planning measures, adapted from a published, untitled series of items created by Rovniak et al for evaluation of technology-mediated health promotion content. 10 EGS and 10 EPS items on a 5-point Likert scale. Range: 1 (does not describe) to 5 (describes completely) of the goal setting and planning strategies. The higher the score means more exercise goal-setting and planning behavior. (Rovniak et al. Annals of Behavioral Medicine, 2002, 24(2): 149-156.)
Baseline to 14 weeks
Walking Skills in Daily Life
Time Frame: Baseline to 14 weeks
Walking skills as measured by the Figure-of-8 Walk test
Baseline to 14 weeks
Hand Grip Strength
Time Frame: Baseline to 14 weeks
Flexor muscle strength of hand and forearm measured by dynamometer
Baseline to 14 weeks
Physical Function as Measured by the Senior Fitness Test
Time Frame: Baseline to 14 weeks
Physical function scores on six components: chair stands, arm curls, chair sit and reach, back scratch, 8 foot up and go, and 2 minute step in place test
Baseline to 14 weeks
Body Weight in kg
Time Frame: Baseline to 14 weeks
Mean body weight as measured by a calibrated scale in a cancer clinic setting
Baseline to 14 weeks
Waist Circumference in cm
Time Frame: Baseline to 14 weeks
Mean waist circumference as measured by Seca-203 measuring tape
Baseline to 14 weeks
Dietary Pattern
Time Frame: Baseline to 14 weeks
Dietary pattern change measured by the National Health and Nutrition Examination Survey (2009-10) measuring fruits, vegetables, dairy/calcium, added sugar, whole grains/fiber, red meat, and processed meat consumption within the past 30 days
Baseline to 14 weeks
Self-reported Physical Activity Minutes
Time Frame: Baseline to 14 weeks
Minutes of physical activity as self-reported using the Community Healthy Activities Model Program for Seniors questionnaire
Baseline to 14 weeks
Self-reported Physical Function
Time Frame: Baseline to 14 weeks
Physical function score as measured by the PROMIS cancer-specific instrument (PROMIS-CA Bank v1.1-Physical Function)
Baseline to 14 weeks
Exercise Motivation Measured as Autonomous Regulation
Time Frame: Baseline to 14 weeks
Autonomous regulation as measured by the Behavioral Regulation in Exercise Questionnaire-2
Baseline to 14 weeks
Psychological Feelings Related to Exercise
Time Frame: Baseline to 14 weeks
Perceptions of autonomy, competence, and relatedness as measured by the Basic Psychological Needs in Exercise scale. 11 items on a 5-point Likert scale. Range: 1 (I do not agree at all) to 5 (I completely agree) for each of the constructs-autonomy (1-20), competence (1-20), and relatedness (1-15). The higher the score means more autonomy, more competence, and relatedness.
Baseline to 14 weeks
Feasibility - Adherence
Time Frame: Baseline to 14 weeks
Adherence as measured by number of participants who complete at least 80% of program activities
Baseline to 14 weeks
Feasibility - Attrition
Time Frame: Baseline to 14 weeks
Attrition as measured by percentage of people who drop out of the program
Baseline to 14 weeks
Feasibility - Technological Issues
Time Frame: Baseline to 14 weeks
Technological issues will be measured by counting the number of reported occurrences
Baseline to 14 weeks
Feasibility - Adverse Events
Time Frame: Baseline to 14 weeks
Adverse events will be measured by counting the number of occurrences
Baseline to 14 weeks
Acceptability Scale
Time Frame: Baseline to 14 weeks

Acceptability and satisfaction will be assessed via Vandelanotte questionnaire with 5-point scale responses, measures are adapted from a published, untitled series of items created by Vandelanotte et al for evaluation of technology-mediated health promotion content. Acceptability and feasibility of 3 components on a 5-point Likert scale-activity monitor (7-item), program team (6-item), and the program itself (15-item). Ranged: 1 (strongly disagree) to 5 (strongly agree). The higher the score means that it is more acceptable and feasible.

(Vandelanotte, C. and I. De Bourdeaudhuij (2003). "Acceptability and feasibility of a computer-tailored physical activity intervention using stages of change: project FAITH." Health Educ Res 18(3): 304-317 and Vandelanotte, C., et al. (2004). "Acceptability and feasibility of an interactive computer-tailored fat intake intervention in Belgium." Health Promot Int 19(4): 463-470.)

Baseline to 14 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth J Lyons, PhD, MPH, University of Texas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2020

Primary Completion (Actual)

January 29, 2022

Study Completion (Actual)

March 29, 2022

Study Registration Dates

First Submitted

January 30, 2020

First Submitted That Met QC Criteria

February 4, 2020

First Posted (Actual)

February 7, 2020

Study Record Updates

Last Update Posted (Actual)

June 8, 2023

Last Update Submitted That Met QC Criteria

May 12, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 16-0040-02
  • 5P30AG024832 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Active video game teleconference support group

3
Subscribe